Upload
laura-gosnell
View
1.039
Download
0
Tags:
Embed Size (px)
Citation preview
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Introduction to Clinical Pharmacology
Chapter 22-Antidepressant Drugs
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Tricyclic Antidespressants: ActionsTricyclic Antidespressants: Actions• Increase sensitivity in postsynaptic alpha (a)-
adrenergic, serotonin receptors
• Decreases sensitivity-presynaptic receptor sites
• Makes neurotransmission activity more effective
• Inhibits reuptake of norepinephrine or serotonin in brain
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Tricyclic Antidespressants: Uses Tricyclic Antidespressants: Uses • Used to treat:
– Depressive episodes
– Bipolar disorder; Obsessive-compulsive disorders; Chronic neuropathic pain
– Depression-anxiety disorders; Enuresis; Peptic ulcer disease; Sleep apnea; Panic disorder
– Bulimia nervosa; Premenstrual symptoms; Dermatological problems; Psychotherapy- severe cases
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Tricyclic Antidespressants: Adverse Reaction and ContraindicationsTricyclic Antidespressants: Adverse Reaction and Contraindications• Adverse reactions: Sedation, dry mouth,
visual disturbances, urinary retention, constipation, photosensitivity
• TCS contraindications: Hypersensitivity to drugs, patients on MAOI antidepressants, myocardial infarction, children, lactating mothers; sinequan contraindications- glaucoma, urinary retention
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Tricyclic Antidespressants: PrecautionsTricyclic Antidespressants: Precautions• Used cautiously in patients:
– Cardiac disease, hepatic and/or renal impairment, hyperthyroid disease
– History of seizure activity, narrow angle glaucoma or increased intraocular pressure
– Urinary retention, and risk of suicide ideation or behavior
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Tricyclic Antidespressants: InteractionsTricyclic Antidespressants: Interactions
Interactant drug Effect of interaction
Sedatives, hypnotics, analgesics
Increased risk ofrespiratory, nervoussystem depression
Dicumarol Increased risk for bleeding
Cimetidine (tagamet) Increased anticholinergicsymptoms (dry mouth, urinary retention, blurred vision)
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Tricyclic Antidespressants: Interactions (cont’d)Tricyclic Antidespressants: Interactions (cont’d)
Interactant drug Effect of interaction
MAOIs Increased risk for hypertensive episodes, severe convulsions, and
hyperpyretic episodes
Adrenergic agents Increased risk for arrhythmias and hypertension
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Monoamine Oxidase Inhibitors: Actions and Uses Monoamine Oxidase Inhibitors: Actions and Uses • Actions: Increase in endogenous epinephrine,
norepinephrine, dopamine, serotonin in nervous system, increase in neurohormones
• Uses: Depressive episodes, psychotherapy, bulimia, night terrors, migraine headaches, seasonal affective disorder, multiple sclerosis
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Monoamine Oxidase Inhibitors: Adverse Reaction Monoamine Oxidase Inhibitors: Adverse Reaction
– Neuromuscular reactions: Orthostatic hypotension, dizziness, vertigo, headache, blurred vision
– Gastrointestinal (GI) and genitourinary (GU) system reactions: Constipation, dry mouth, nausea, diarrhea, impotence
– Serious adverse reaction: Hypertensive crisis foods containing tyramine
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Monoamine Oxidase Inhibitors: Contraindications and Precautions Monoamine Oxidase Inhibitors: Contraindications and Precautions • Contraindications: Elderly patients;
hypersensitivity to drugs; pheochromocytoma; liver, kidney or cerebrovascular disease; hypertension; history of headaches; congestive heart failure
• Caution: Patients with impaired liver function; history of seizures; parkinsonian symptoms; diabetes; hyperthyroidism; risk of suicidal ideation or behavior
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Monoamine Oxidase Inhibitors: InteractionsMonoamine Oxidase Inhibitors: InteractionsInteractant drug Effect of interaction
sedatives, hypnotics, and analgesics
Increased risk for adverse reactions during surgery
Thiazide diuretics Increased hypotensive effects of the MAOI
Meperidine (demerol) Increased risk for hypertensive episodes, severe convulsions, hyperpyretic episodes
Adrenergic agents Increased risk for cardiac arrhythmias, hypertension
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Monoamine Oxidase Inhibitors: InteractionsMonoamine Oxidase Inhibitors: Interactions
Interactant drug Effect of interaction
Tyramine or tryptophan Hypertensive crisis, which may occur up to 2 weeks after the MAOI is discontinued
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Selective Serotonin Reuptake InhibitorsSelective Serotonin Reuptake Inhibitors• Actions: Stimulant to reverse depression
• Uses: Depressive episodes, bulimia nervosa, panic, premenstrual, post-traumatic stress disorders, anxiety and social phobias, Raynaud’s disease, migraine headaches, diabetic neuropathy, hot flashes
• Adverse Reactions
– Neuromuscular Reactions: Somnolence, dizziness, headache, insomnia, tremor, weakness
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Selective Serotonin Reuptake Inhibitors (cont’d)Selective Serotonin Reuptake Inhibitors (cont’d)
– Gastrointestinal, genitourinary system reactions: Constipation, dry mouth, nausea, pharyngitis, runny nose, abnormal ejaculation
• Contraindications: Hypersensitivity to drugs; pregnancy category C, patients taking cisapride, pimozide or carbamazepine should not take fluvoxamine (prozac)
• Precautions: Diabetes mellitus; cardiac disease; impaired liver, or kidney function; risk of suicidal ideation or behavior
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Selective Serotonin Reuptake Inhibitors: InteractionsSelective Serotonin Reuptake Inhibitors: Interactions
Interactant drug Effect of interaction
Other antidepressants Increased risk of toxic effects
Cimetidine (Tagamet) Increased anticholinergic symptoms
Aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs), e.g., ibuprofen
Increased risk for GIbleeding
Lithium (interaction with fluoxetine)
Increased risk of lithium toxicity
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Miscellaneous Antidepressants: Actions and Uses Miscellaneous Antidepressants: Actions and Uses • Affects: Neurotransmission of serotonin,
norepinephrine, dopamine
• Uses: Depressive episodes, anxiety disorders, neuropathic pain, enhancing weight loss, treating aggressive behaviors, menstrual disorders, cocaine withdrawal, alcohol cravings, fibromyalgia, stress incontinence
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Miscellaneous Antidepressants: Adverse ReactionsMiscellaneous Antidepressants: Adverse Reactions
• Neuromuscular reactions: Somnolence, migraine headache, hypotension, dizziness, lightheadedness, vertigo, blurred vision, photosensitivity, insomnia, nervousness or agitation, tremor
• Gastrointestinal reactions: Nausea, dry mouth, anorexia, thirst, diarrhea, constipation, bitter taste
• Generalized body system reactions
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Miscellaneous Antidepressants: Contraindication and PrecautionsMiscellaneous Antidepressants: Contraindication and Precautions
• Contraindications: Hypersensitivity-drugs, maprotiline- seizure disorder, patients on cisapride, pimozide, carbamazepine
• Precautions: Cardiac disease; renal and/or hepatic impairment; hyperthyroid disease; risk of suicidal ideation or behavior
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Miscellaneous Antidepressants: InteractionsMiscellaneous Antidepressants: Interactions Interactant drug Effect of interaction
Sedatives, hypnotics and analgesics
Increased risk for respiratory & nervous system depression
Warfarin (Coumadin) and cimetidine (Tagamet)
Increased risk for bleeding, increased anticholinergic symptoms
Antihypertensive agents Increased risk for hypotension
MAOIs Increased risk for hypertensive episodes, severe convulsions, & hyperpyretic episodes
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: AssessmentNursing Process: Assessment• Preadministration assessment:
– Obtain medical history
– Assess mental status, subjective feelings, slowness to answer questions, monotone speech pattern, sadness or crying
– Physical assessment including blood pressure, pulse, respiratory rate, weight, suicidal thoughts
– Ask about intent using simple, straight-forward questions
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: AssessmentNursing Process: Assessment
• Ongoing assessment:
– Monitor vital signs, report change to primary healthcare provider
– Observe response to therapy
– Document general summary- outward behavior, complaints, problems, compare previous notations, observations
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: Nursing Diagnosis and PlanningNursing Process: Nursing Diagnosis and Planning• Self-Care Deficit Syndrome
• Disturbed sleep pattern
• Nutrition, imbalanced less than bodily requirements
• Risk for suicide
• Pain
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: Nursing Diagnosis and PlanningNursing Process: Nursing Diagnosis and Planning• The expected outcome includes an optimal
response to therapy:
– Reason for administration of antidepressant
– Optimal response to drug therapy
– Support patient for adverse drug reactions
– Understanding, compliance: Prescribed therapeutic regimen
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: ImplementationNursing Process: Implementation• Promoting an optimal response therapy:
– Observe patient for adverse reactions: Notify primary health care provider
– Observe: Behavioral changes during initial therapy when dosage increased, decreased
– Patients with depression: Develop nursing care plan, antidepressants, keep patient lying down for 30 minutes
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: ImplementationNursing Process: Implementation
• Monitoring and managing patient’s need:
– Self-care deficit syndrome
• Assist when depression- no physical, or emotional energy to perform self-care activities
• Minimize injury risk: Safe environment, assist in changing positions, Assist-activities of daily living, encourage self care, give positive feedback, write behavioral records-periodic intervals, frequency depends– hospital, unit guidelines
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: ImplementationNursing Process: Implementation• Monitoring and managing patient’s need
(cont’d):
– Disturbed sleep pattern: Promote sleep, wakefulness during day, shut drape at night, opened in day, help patient reorient to day, night time
– Imbalanced nutrition, less than bodily requirements:
•Monitor fluid dietary intake, monitor weight loss, gain, good oral hygiene, frequent sips of fluids, sugarless gum
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: ImplementationNursing Process: Implementation• Monitoring and managing patient’s need
(cont’d):
•Strict dietary control- foods containing tyramine not be eaten for patients on MAOIs, no food from outside
– Risk for suicide: Well-supervised environment, wait for therauptic effect; report for: expressions of guilt, hopelessness, helplessness, insomnia, weight loss, direct/indirect threats of suicide, care while swallowing
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: ImplementationNursing Process: Implementation• Monitoring and managing patient’s need
(cont’d):
– Pain, Acute:
•Drugs: Trazodone, priapism-impotence, prolonged, inappropriate penile erection, injection of alpha-adrenergic stimulants, surgical intervention
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: ImplementationNursing Process: Implementation
• Educating the patient and family
– Managing reactions; patients- continue proper drug regimen, evaluate ability to take responsibility of drugs, explain adverse reactions
– Teaching plan: Inform primary health care provider, dentist; dizziness: rise slowly of bed, chair; help changing positions; relieve dry mouth: frequent sips-water, sucking hard candy, chewing gum
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: ImplementationNursing Process: Implementation• Educating the Patient and Family (cont’d)
– Teaching plan: Report: Unusual changes, physical effects; avoid prolonged: exposure to sunlight or sunlamps; male patients: Experience prolonged, inappropriate, painful erections-stop drug, notify primary care provider
• Evaluation
– Therapeutic effect: Achieved
– No evidence of injury apparent
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: ImplementationNursing Process: Implementation• Evaluation (cont’d):
– Patient: Perform self-care
– Adverse reactions: Identified, reported primary health care provider, managed successfully- appropriate nursing interventions
– Patient verbalizes: Treatment modalities, importance continued follow-up care
– Patient and family demonstrate: Drug regimen
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
End of Presentation